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Abstract
Background: Pneumonia is the leading cause of child deaths globally. The aims of this study were to: a) estimate the
number and global distribution of pneumonia deaths for children 1–59 months for 2008 for countries with low (,85%) or
no coverage of death certification using single-cause regression models and b) compare these country estimates with
recently published ones based on multi-cause regression models.
Methods and Findings: For 35 low child-mortality countries with ,85% coverage of death certification, a regression model
based on vital registration data of low child-mortality and .85% coverage of death certification countries was used. For 87
high child-mortality countries pneumonia death estimates were obtained by applying a regression model developed from
published and unpublished verbal autopsy data from high child-mortality settings. The total number of 1–59 months
pneumonia deaths for the year 2008 for these 122 countries was estimated to be 1.18 M (95% CI 0.77 M–1.80 M), which
represented 23.27% (95% CI 17.15%–32.75%) of all 1–59 month child deaths. The country level estimation correlation
coefficient between these two methods was 0.40.
Interpretation: Although the overall number of post-neonatal pneumonia deaths was similar irrespective to the method of
estimation used, the country estimate correlation coefficient was low, and therefore country-specific estimates should be
interpreted with caution. Pneumonia remains the leading cause of child deaths and is greatest in regions of poverty and
high child-mortality. Despite the concerns about gender inequity linked with childhood mortality we could not estimate
sex-specific pneumonia mortality rates due to the inadequate data. Life-saving interventions effective in preventing and
treating pneumonia mortality exist but few children in high pneumonia disease burden regions are able to access them. To
achieve the United Nations Millennium Development Goal 4 target to reduce child deaths by two-thirds in year 2015 will
require the scale-up of access to these effective pneumonia interventions.
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Introduction
Pneumonia is the leading cause of death in children under the
age of 5 years, with more than 98% of pneumonia deaths
occurring in developing countries [1]. Among children who
survive, pneumonia is a major cause of illness globally with an
estimated 156 million new episodes occurring each year, 8% of
which are severe and require hospitalization [2]. In 2009, a Global
Action Plan for Prevention and Control of Pneumonia (GAPP) was
launched by the World Health Organization (WHO), UNICEF
and partners, with the aim of increasing awareness of pneumonia
as a major cause of death and promoting the use of interventions
with proven effectiveness [3]. In 2010 the World Health Assembly
recognised the importance of pneumonia as a global health
problem and passed the resolution ‘‘Accelerating progress towards
achievement of Millennium Development Goal 4 (MDG4) to
reduce mortality: prevention and control of pneumonia’’.
Quantifying the burden of disease due to pneumonia is essential
to monitor progress towards MDG4.
Since many high under-five mortality rate (U5MR) countries
lack complete death registration, several attempts have been made
to estimate the burden of child pneumonia mortality using single-
or multi-cause statistical models. In the single-cause model, the
proportion of pneumonia deaths is estimated using a log-linear
regression that can include several covariates. Previously, a single-
cause model published in 2002 estimated that child deaths from
pneumonia accounted for approximately 19% of all deaths for the
year 2000 [4]. In the multi-cause model one cause of death is
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25095
selected as the base cause and the ratio of the proportion of each of
the other causes of death relative to the proportion of the ‘base’
cause is estimated using an ordinary least squares regression [5]. A
multi-cause model estimate for countries without adequate vital
registration systems published in 2003 estimated that child
pneumonia deaths accounted for 23% of all child deaths in sub-
Saharan Africa and South Asia for the year 2000 [6]. More
recently, multi-cause model based estimates were published and
suggested that neonatal and post-neonatal pneumonia deaths
accounted for 18% of all child deaths for the year 2008 [1].
In this paper, we provide year 2008 pneumonia mortality
estimates for children 1–59 months for countries with low (,85%)
or no coverage of death certification (n= 122 countries) using a
single-cause model similar to that used to provide year 2000
estimates previously [4]. We also compare the single-cause
pneumonia mortality estimates with those recently published
using a multi-cause model [1].
Methods
Pneumonia mortality post-neonatal estimates
The number of post-neonatal pneumonia deaths for 122
countries was estimated using two different methods according
to the U5MR and gross national income per capita at purchasing
power parity (GNI PPP) of the countries. A detailed description for
each step is presented in Table 1 and, Supplementary panel
S1.
Vital registration model (VRM) for countries of low
mortality (U5MR) and low VR coverage
For 35 countries with U5MR,26 per 1000 live births or of GNI
PPP .$7,510 (international dollars) but inadequate death
registration (,85%), estimates of post-neonatal pneumonia deaths
and 95% confidence intervals (95% CI) were produced using a
single-cause regression model that used death registration data
from 64 low mortality countries with high quality VR data
(extracted from the WHO Mortality Database using the
International Classification of Diseases 9 and 10 versions). This
model included covariates for U5MR, GNI PPP per capita and a
regional indicator variable for WHO classification regions
(Supplementary panel S1).
Verbal autopsy models (VAM) for countries of high
mortality (U5MR)
For 87 countries with U5MR$26 per 1000 live births
pneumonia deaths and 95% CI were estimated based on single
cause regression models developed from verbal autopsy studies
(VAM). China’s U5MR in 2008 was 20.5/1000 LB. However
China was included in this category given that this country’s
profile is closer to the one of the high mortality countries and its
GNI PPP was ,$7510 in 2008.
Search strategy. The search strategy that was used to
identify verbal autopsy studies and the inclusion criteria of the
selected ones is presented in Table 1. Included studies were
community-based, longitudinal multi-cause studies (studies
reporting at least two different causes of death) or control arms
of clinical trials of child mortality. Those studies were obtained
through a literature search of Pubmed for the period between
1980 and 2009, using the keywords ‘‘pneumonia’’ and’’ mortality’’
and restricting the search to children. The search returned 2234
papers for further evaluation. We first excluded duplicate studies
and studies that did not estimate mortality in children 0–4yrs in
developing countries and did not report overall U5MR at the
study site. We then excluded any studies that were not community-
based and were not longitudinal or national based data or control
arms of intervention trials. In the next step we excluded all studies
that did not have duration of at least 12 months (prospective or
retrospective studies) or did not include subjects of exactly the
same age range (birth cohorts). We then excluded all studies that
did not use verbal autopsies to assign the cause of death. In the
next step we excluded any single-cause studies, as single cause
studies tend to over-estimate the cause of death they are
Table 1. Methods for estimating pneumonia child mortality in all countries (U5MR: under five mortality rate, GNI PPP: gross
national income per capita at purchasing power parity, VR: vital registration, HIV ANC: index score for HIV prevalence based on the
antenatal care surveillance; China U5MR in 2008 was 20.5/1000lb, however it was included in the Verbal autopsy model given that
this country’s profile is closer to the one of the high mortality countries and its GNI PPP was ,$7510 in 2008).
Vital registration model (35 countries)
Verbal autopsy model
(87 countries)
Countries a. U5MR ,26/1000lb or GNI PPP .$7510
b. VR coverage ,85%
U5MR $26/1000lb
Sources VR data from low mortality - high
coverage countries
a. PubMed search using the following keywords:
Pneumonia, mortality
b. Published from 1980-01-01 to 2008-11-01
Inclusion criteria n/a a. Estimated pneumonia proportionate mortality in children 0–4yrs in
developing countries and reported overall U5MR at the study site
b. Were community-based and longitudinal OR national based data OR
control arms of intervention trials
c. Had a duration of at least 12 months (prospective or retrospective
studies) OR included subjects of exactly the same age range (birth
cohorts)
d. Used verbal autopsies to assign the cause of death
e. Estimated mortality from at least two unique causes
f. Had reported more than 50 deaths and had no more than 1/3 of deaths
attributed to undetermined causes
Model Single cause regression model including the
following covariates: U5MR, GNI PPP and
WHO area
Single cause regression model including the following covariates:
U5MR, HIV ANC, malaria prevalence, two variables for the lower and
upper age bounds
doi:10.1371/journal.pone.0025095.t001
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examining. Finally, we excluded studies with fewer than 50 deaths
and studies that had more than 1/3 of deaths attributed to
undetermined causes, adhering to standard Child Health
Epidemiology Reference Group (CHERG) methods [7,8].
Eventually, we included 58 studies (81 data points) published
between 1986 and 2008 for statistical modeling. The geographic
location of the 81 data points is shown in Supplementary
figure S1. In brief, 37 studies were conducted in South East Asian
region, 25 were conducted within the African region, 10 were
conducted in the Americas region, seven were conducted in the
East Mediterranean region and two were conducted in the West
Pacific region.
Some studies reported also malnutrition as a cause of death.
These malnutrition deaths were reallocated to other related
(infectious) causes of death that were reported in the study (e.g.
pneumonia, diarrhea, malaria) [6]. In addition, in some studies
multi-cause deaths were reported (for example one child had as
cause of death diarrhea and pneumonia). These multi-cause
deaths were reallocated to each related cause according to the
proportion of the single-cause deaths in the study (for example:
one study reported 80 pneumonia deaths, 60 diarrhea deaths and
20 pneumonia-diarrhea deaths. Of the 20 multi-cause deaths 11
were re-distributed to the pneumonia deaths and 9 to the diarrhea
deaths based on the proportion of the single cause pneumonia and
diarrhea deaths (80/60= 1.3)).
Verbal autopsy models. The number of pneumonia deaths
for children aged 1–59 months in the 85 high mortality countries
was estimated using two single cause regression models. For the
first one we used studies that were conducted in sub-Sahara
African settings (VAM1a) and for the second we used studies that
were conducted in settings of developing countries not in the sub-
Sahara region (VAM1b). The covariates for both models were
U5MR, an index score for malaria prevalence (described in detail
in [5]), an index score for HIV prevalence based on the antenatal
care (ANC) surveillance and two variables for the lower and upper
age bounds. Studies were given a weight proportional to the
square root of the number of deaths on which they had data. The
models were then populated with year 2008 country-level
covariate data in order to estimate the proportion of pneumonia
deaths for the high mortality countries. The HIV ANC score of
the studies that were included to develop the models ranged from
0 to 7. However eight sub-Saharan countries had an HIV ANC
score above 7. For these eight countries we used a model that did
not include the HIV covariate and when populating the model we
used their HIV-free envelopes of all deaths (Supplementary
panel S1).
Regional and national estimates
Country-level post-neonatal pneumonia estimates (derived
either from the VR or VA models) were adjusted post-hoc for
the use of Haemophilus influenzae type b (Hib) vaccine, in order to
account for the impact of Hib vaccination scale-up in 2008. In
particular, for each country we extracted the number of possible
prevented number of post-neonatal Hib pneumonia deaths, which
were estimated by multiplying the vaccine immunization coverage
for three doses of Hib (Hib3; extracted from UNICEF, [9]) by the
vaccine efficacy of Hib3 against chest X-ray confirmed pneumonia
[10]. Regional estimates of post-neonatal pneumonia deaths were
obtained by adding together the country-level data for the six
WHO regions.
Sensitivity analysis
We conducted several sensitivity analyses to check how model-
dependent the estimates were. In particular for the 87 high
mortality countries we applied (i) two VA models (one for the sub-
Sahara high mortality countries and one for the remaining high
mortality countries) adjusted only for U5MR and the two age-
related variables (VAM2a and VAM2b); (ii) one global model (for
all 85 high mortality countries) adjusted for U5MR, an index score
for malaria prevalence, an index score for HIV prevalence based
on ANC surveillance and the two age-related variables (VAM3);
and (iii) one global model (for all 85 high mortality countries)
adjusted only for U5MR and the two age-related variables
(VAM4). In addition, we conducted a total, regional and national
comparison between the current single-cause based estimates and
the multi-cause based estimates of the year 2008 [1].
Results
Vital registration model (VRM) for countries of low
mortality
The parameter estimates of the VR model are presented in
Table 2. For the year 2008, there were 35 countries of low
mortality but with low VR data coverage (Supplementary table
S1) and their post-neonatal child pneumonia deaths were
estimated using the VR model. The U5MR for the 35 VRM
countries ranged from 3.6/1000 LB in Andorra to 67.1/1000 LB
in South Africa.
Verbal autopsy models (VAM) for countries of high
mortality
The parameter estimates of the two VA models are presented in
Table 2. For the year 2008, there were 87 high mortality
countries (Supplementary table S1) and their post-neonatal
pneumonia deaths were estimated using the VA models. The
U5MR for the 85 VAM countries ranged from 20.5/1000 LB in
China to 257/1000 LB in Afghanistan. The VAM1a was
populated for 44 high mortality sub-Sahara African countries
and the VAM1b was populated for the 43 remaining high mortality
developing countries.
Total, regional and national estimates
Total post-neonatal pneumonia deaths for the year 2008 were
estimated to be 1.18 M (95% CI: 0.77 M, 1.80 M), accounting for
23.27% (95% CI: 17.15%, 32.75%) of all post-neonatal deaths
(Table 3). WHO regional post-neonatal mortality estimates are
presented in Table 3. The countries with the highest absolute and
relative post-neonatal pneumonia mortality are presented in
Table 4 and national estimates of absolute and relative
pneumonia mortality for post-neonatal children are presented in
Supplementary table S1 and Figures 1 and 2.
The results of the sensitivity analysis of the 87 high mortality
countries are presented in Table 5. Post neonatal pneumonia
death estimates were consistent with 3 out of the 4 approaches
predicting an estimate of 1.17 M to 1.18 M post-neonatal
pneumonia deaths. The total, regional and national comparison
between the current single-cause based estimates and the multi-
cause based estimates of the year 2008 [1] are presented in
Supplementary table S2. Both models estimated that child
pneumonia deaths accounted for 23% of all cause post-neonatal
child deaths of the 122 countries. In terms of regional differences,
the estimates from both models were relatively consistent for
countries from the Africa, East Mediterranean and South East
Asia WHO regions but not for countries from the America,
Europe and West Pacific WHO regions (with estimates varying by
1.2%, 4.46%, 5.57%, 9.38%, 14.08% and 13.76% respectively;
Supplementary table S2). Finally, the correlation coefficient
Estimate of Child Post-Neonatal Pneumonia Deaths
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for the agreement between the national estimates was 0.40
(Supplementary Figure S2).
Discussion
Estimates
We estimated that there were 1.18 M (95% CI 0.77 M, 1.80 M)
post-neonatal pneumonia deaths in the year 2008, representing
23.27% (95% CI: 17.15%, 32.75%) of all post-neonatal deaths in
122 countries of low or no death certification. The WHO region
with the highest number of pneumonia deaths was the African
region (with 569,940 post-neonatal pneumonia deaths), whereas
the regions with the highest percentage of post-neonatal
pneumonia deaths were the East Mediterranean and South East
Asian regions (with 30.69% and 31.45% of all post-neonatal
deaths respectively). The countries with the highest number of
pneumonia deaths were India, Nigeria, Democratic Republic of
the Congo, Pakistan, Afghanistan and Ethiopia and these
accounted for more than 55% of total pneumonia deaths.
We elected to account for malaria and HIV infection in our
models. The assumption is that in areas where malaria is highly
prevalent (mainly in countries of the Sub-Saharan Africa),
malaria’s attributable mortality will be high and thus needs to be
taken into account. In addition, low birth weight because of
maternal malaria infection may make the child more susceptible to
poor prognosis from childhood infections. Thus malaria needs to
be taken into account as an alternative cause of child death and as
an indirect contributor through low birth weight. With regard to
HIV, we included HIV prevalence in our models for similar
reasons (i.e. HIV’s attributable mortality in countries of high
prevalence, increased susceptibility of HIV+ children to and
increased mortality from infections including pneumonia). How-
ever, there is limited information about the effect of HIV infection
on childhood pneumonia related morbidity and mortality and
further research needs to be conducted.
It is notable that despite general concerns about gender inequity
linked with childhood mortality we could not estimate sex-specific
pneumonia proportionate mortality due to inadequate data. In
Table 2. Parameter estimates for the vital registration and verbal autopsy models (lnU5MR: Natural logarithm of the under 5
mortality rate; GNI: Gross National Income; WHO: World Health Organisation).
Models Predictors
Parameter
Estimate R2
Vital registration model lnU5MR 0.17 0.52
GNI 20.00
WHO region 20.18
Verbal autopsy models
Model for Sub-Sahara African countries lnU5MR 0.24 0.41
Malaria 20.40
HIV 20.04
Model for non Sub-Sahara African high mortality countries lnU5MR 0.32 0.32
Malaria 0.39
HIV 20.09
doi:10.1371/journal.pone.0025095.t002
Table 3. Post-neonatal pneumonia number of deaths and mortality rates for the WHO regions (PN: Pneumonia; 95% CI: 95%
Confidence Interval; WHO: World Health Organisation).
Regions
# of 1–59m PN
deaths (95% CI)
# of 1–59m PN deaths over 1–59m
total deaths (95% CI)
122 countries 1181037
(773857, 1803686)
23.27%
(17.15%, 32.75%)
WHO region
Countries from Africa WHO region (n = 44 of 46) 569940
(358622, 896048)
19.22%
(12.09%, 30.22%)
Countries from America WHO region (n = 15 of 35) 9149
(5218, 15706)
16.59%
(9.46%, 28.47%)
Countries from East Mediterranean WHO
region (n = 19 of 21)
207061
(141241, 306405)
30.69%
(20.93%, 45.41%)
Countries from Europe WHO region (n = 15 of 53) 6983
(4470, 10945)
16.01%
(10.25%, 25.09%)
Countries from South East Asia WHO region (n = 11 of 11) 336329
(234801, 484244)
31.45%
(21.96%, 45.29%)
Countries from West Pacific WHO region (n = 18 of 27) 51575
(29504, 90337)
20.79%
(11.89%, 36.42%)
doi:10.1371/journal.pone.0025095.t003
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particular, we could only identify four studies that reported child
mortality in girls and boys separately. Gender inequity could occur
with parents being more likely to seek care and receive treatment
for sick sons than daughters [11]. We recommend that future
studies report (pneumonia) mortality rates separately for boys and
girls so that investigation of these issues can be conducted.
Temporal trends in pneumonia mortality
When comparing the number of estimated child pneumonia
deaths between the years 2000–2003 [12] and 2008, we observed
a 27% reduction in pneumonia mortality. This reduction may be
explained by a general decrease in the overall child mortality in
developing countries. In particular, in the years 2000–2003 the
average annual total number of child deaths under five years old
was 10.4 M, whereas it was 8.8 M deaths in 2008 [13],
corresponding to a decline of 15%. Given the reduction in
U5MR over this period, the fall in the proportion of child deaths
due to pneumonia can be explained in part by the clear observed
association between overall U5MR and the proportion of under
five deaths due to pneumonia. This relationship is likely to be
multifactorial and due in part to general socio-economic
development (and associated changes in factors such as fertility
and maternal education and empowerment) and in part due to
development of general health services infrastructure and specific
health programmes. In recent years the latter has included the
introduction of effective new vaccines against bacterial pneumonia
such as Hib vaccine and pneumococcal conjugate vaccines (PCVs),
however these vaccines have been implemented mainly in
countries of lower mortality and therefore these interventions
probably had a limited impact on global pneumonia mortality
estimates [14]. In particular, for the year 2008, none of the 87 high
mortality countries (including India and China) had introduced
the PCV in their immunisation programmes, and only 41 of them
had introduced the HibCV, with the average coverage being 75%
(ranging from 10% to 99%). In addition, none of the six countries
Table 4. Countries with the highest absolute and relative
post-neonatal pneumonia mortality ordered by rank.
Rank # of 1–59m PN deaths
% of 1–59m PN deaths over
1–59m total deaths
1 India Cape Verde
2 Nigeria Pakistan
3 Dem. Rep. of the Congo Bhutan
4 Pakistan Timor-Leste
5 Afghanistan Lesotho
6 Ethiopia Nauru
7 China Myanmar
8 Kenya Djibouti
9 Sudan Sri Lanka
10 Angola Bangladesh
11 Bangladesh Somalia
12 Indonesia Mauritania
13 Uganda India
14 United Republic
of Tanzania
Nepal
15 Myanmar Sudan
16 Niger Yemen
17 Somalia Ethiopia
18 Burkina Faso Comoros
19 Chad Egypt
20 Mali Sao Tome and Principe
doi:10.1371/journal.pone.0025095.t004
Figure 1. National estimates of number of pneumonia deaths for children 1–59 months (data on 71 low mortality and high vital
registration coverage are extracted from the WHO Mortality Database using the International Classification of Diseases 9 and 10
versions).
doi:10.1371/journal.pone.0025095.g001
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accounting for 55% of all child pneumonia deaths and only 8 of
the 20 high pneumonia mortality countries (Table 4) had
introduced a HibCV vaccination programme (in 2008).
In addition to the overall mortality fall and the socio-economic
developments, the differences that we observe between the years
2000–2003 and 2008 might also be due (at least partly) to
differences in the estimation methods used and therefore should be
interpreted with caution. In particular, the methods that were used
for the production of the current pneumonia mortality estimates
are different in terms of a) the way the under five mortality
envelope is estimated, b) splitting the neonatal and post-neonatal
age periods and c) the way that the proportion of pneumonia
mortality is estimated (see the section improvement from previous
single cause based estimate for more details).
Differences between multi and single-cause based
estimates of post-neonatal pneumonia mortality
We compared the national, regional and total single-cause and
multi-cause based estimates for the year 2008 [1]. The correlation
between the two sets of national post-neonatal estimates was 0.40.
In terms of regional differences, the estimates from both models
were relatively consistent for the Africa, East Mediterranean and
South East Asia regions but not for the America, Europe and West
Pacific regions. Both models estimated that post-neonatal
pneumonia deaths accounted for 23% of all cause deaths in these
122 countries. The global single-cause and multi-cause based
estimates for the proportion of child deaths due to pneumonia for
the year 2008 differed by only 0.35% in absolute and 1.5% in
relative terms. This illustrates a general property of these mortality
Figure 2. National estimates of % pneumonia deaths for children 1–59 months (data on 71 low mortality and high vital registration
coverage are extracted from the WHO Mortality Database using the International Classification of Diseases 9 and 10 versions).
doi:10.1371/journal.pone.0025095.g002
Table 5. Sensitivity analysis for the global post-neonatal pneumonia estimates based on the application of alternative verbal
autopsy models (VAM) for the high mortality countries (Number of pneumonia deaths for low mortality countries and for India and
China are estimated in the same way among all four different approaches; VAM1a & VAM1b are the models presented in the main
analysis; PN: Pneumonia; lnU5MR: Natural logarithm of the under 5 mortality rate; HIV ANC: index score for HIV prevalence based
on the antenatal care surveillance).
Models Model description
Global 1–59 m PN deaths
(% of all 1–59 m deaths)
VAM1a & VAM1b 2 VA models (one for the sub-Sahara high mortality countries and one for the remaining high
mortality countries) adjusted for lnU5MR, an index score for malaria prevalence, the HIV ANC
score and two age-related dummy variables (model presented in the main analysis)
1.18M (23.33%)
VAM2a & VAM2b 2 VA models (one for the sub-Sahara high mortality countries and one for the remaining
high mortality countries) adjusted for lnU5MR and two age-related dummy variables
1.17 M (23.12%)
VAM3 1 global model (for all 85 high mortality countries) adjusted for lnU5MR, malaria prevalence,
HIV ANC and the two age-related dummy variables (VAM3)
1.04 M (20.55%)
VAM4 1 global model (for all 85 high mortality countries) adjusted only for lnU5MR and the two
age-related dummy variables
1.18 M (23.33%)
doi:10.1371/journal.pone.0025095.t005
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models that they yield the most stable and reliable estimates at the
total and regional level but generally should be used for national
planning or monitoring purposes only with great caution.
Improvement from previous single cause based estimate
(high mortality countries)
The previous single-cause based pneumonia mortality estimate
was based on a model developed by Williams et al in 2002 [4].
Although the authors tried to summarise the evidence in the best
possible way there were a few problems that we tried to minimise
in this estimate. In particular, the VA studies that were used to
develop the model (i) were not selected after a truly systematic
review of the literature, (ii) there was a disproportionate number of
studies from South Africa, (iii) the intervention arms of controlled
trials were included, (iv) single-cause studies were not excluded and
(v) it was not clear whether the selected studies included neonatal
deaths and/or neonatal pneumonia deaths. In the current
estimate, we conducted a literature review to find all relevant
studies. We also looked through all the previous reviews to identify
any studies that were not picked up by our search. We included
only the control arms of controlled trials and any single-cause
pneumonia studies were excluded to avoid introduction of bias due
to relative over-reporting of pneumonia deaths. Finally, each study
was screened thoroughly and it was coded according to whether or
not it included neonatal deaths.
In relation to the development of the model, (i) the only covariate
that was used in the previous estimate was U5MR and (ii) the same
model was used to predict the number of pneumonia deaths for all
high mortality countries. In the current estimate we used two
additional covariates (one for HIV and one for malaria prevalence).
In addition we ran several other models including other additional
covariates such as percentage of urban population and an
insecticide treated bed-net (ITN) score but these covariates were
not included in the final model since their inclusion did not increase
the percentage of the variance explained. We also developed
separate models for the sub-Saharan African countries and for the
remaining high mortality countries since the absolute proportions of
the main causes of child death in Africa is different to other high
mortality settings, mainly due to the significant proportion of child
deaths due to malaria in Africa but not in other global regions.
Conclusions
We estimated that 1.18 M post-neonatal children died due to
pneumonia in the year 2008 in 122 countries of low or no vital
registration coverage. The total and regional mortality estimates
proved to be consistent across two (single and multi-cause)
modelling approaches. The accuracy and consistency of these
models may be improved further by adding covariates (e.g. risk
factors such as breastfeeding prevalence, exposure to indoor air
pollution and access to antibiotic treatment) that are associated
with pneumonia mortality, as these data become available. In
addition future models should take into account factors that will
affect future pneumonia and overall child mortality such as the
coverage of pneumococcal and Hib conjugate vaccine coverage,
indicators of paediatric HIV infection and antiretroviral treat-
ment, antibiotic resistance and access to health care. There is
currently very poor reporting of gender-specific mortality rates
and, given recent concerns over gender health inequities, we
recommend that future studies give greater attention to reporting
these data.
The use of global child mortality modelling approaches, such as
those described here, which are based on the best possible locally
appropriate data, can contribute to monitoring of the achievement
of global child mortality targets. Despite the reduction in child
pneumonia deaths between the years 2002 and 2008, pneumonia
still remains one of the main causes of child deaths. The 63rd
World Health Assembly resolution on the control of child
pneumonia represented an important contribution. Achievement
of MDG4 resulting in a 67% reduction of pneumonia deaths by
2015, will correspond to the avoidance of more than a cumulative
5 million child deaths from pneumonia over the period between
2010 and 2015. In order to achieve MDG4 it will be important to
continue to reduce the number of child pneumonia deaths, which
will require scale-up of access to effective pneumonia interventions
and development of interventions to reduce neonatal pneumonia
mortality.
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